NO2015019I1 - Aeromonas salmonicida subspesie salmonicida,inaktivert/ Vibrio salmonicida,inaktivert/ Vibrio anguillarum serotype O1, inaktivert/Vibrio anguillarum serovar O2a, inaktivert/ Moritella viscosa, inaktivert/ Infeksiøs pankreasnekrosevirus (IPVN) serotype Sp/Laksespankreas sykdomsvirus (SPDV) stamme F93-125, inaktivert - Google Patents

Aeromonas salmonicida subspesie salmonicida,inaktivert/ Vibrio salmonicida,inaktivert/ Vibrio anguillarum serotype O1, inaktivert/Vibrio anguillarum serovar O2a, inaktivert/ Moritella viscosa, inaktivert/ Infeksiøs pankreasnekrosevirus (IPVN) serotype Sp/Laksespankreas sykdomsvirus (SPDV) stamme F93-125, inaktivert

Info

Publication number
NO2015019I1
NO2015019I1 NO2015019C NO2015019C NO2015019I1 NO 2015019 I1 NO2015019 I1 NO 2015019I1 NO 2015019 C NO2015019 C NO 2015019C NO 2015019 C NO2015019 C NO 2015019C NO 2015019 I1 NO2015019 I1 NO 2015019I1
Authority
NO
Norway
Prior art keywords
inactivated
salmonicida
vibrio
vibrio anguillarum
ipvn
Prior art date
Application number
NO2015019C
Other languages
English (en)
Original Assignee
Pharmaq As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40469649&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2015019(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmaq As filed Critical Pharmaq As
Publication of NO2015019I1 publication Critical patent/NO2015019I1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0233—Rickettsiales, e.g. Anaplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/107—Vibrio
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/116—Polyvalent bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/18—Togaviridae; Flaviviridae
    • C07K14/1808—Alphaviruses or Group A arboviruses, e.g. sindbis, VEE, EEE, WEE, semliki forest virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36161—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO2015019C 2008-02-08 2015-08-03 Aeromonas salmonicida subspesie salmonicida,inaktivert/ Vibrio salmonicida,inaktivert/ Vibrio anguillarum serotype O1, inaktivert/Vibrio anguillarum serovar O2a, inaktivert/ Moritella viscosa, inaktivert/ Infeksiøs pankreasnekrosevirus (IPVN) serotype Sp/Laksespankreas sykdomsvirus (SPDV) stamme F93-125, inaktivert NO2015019I1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NO20080711 2008-02-08
NO20080885 2008-02-20
NO20090290A NO333242B1 (no) 2008-02-08 2009-01-20 Sammensetning, medisinsk anvendelse og fremgangsmate som omfatter salmonid alfavirus

Publications (1)

Publication Number Publication Date
NO2015019I1 true NO2015019I1 (no) 2015-08-10

Family

ID=40469649

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20090290A NO333242B1 (no) 2008-02-08 2009-01-20 Sammensetning, medisinsk anvendelse og fremgangsmate som omfatter salmonid alfavirus
NO2015019C NO2015019I1 (no) 2008-02-08 2015-08-03 Aeromonas salmonicida subspesie salmonicida,inaktivert/ Vibrio salmonicida,inaktivert/ Vibrio anguillarum serotype O1, inaktivert/Vibrio anguillarum serovar O2a, inaktivert/ Moritella viscosa, inaktivert/ Infeksiøs pankreasnekrosevirus (IPVN) serotype Sp/Laksespankreas sykdomsvirus (SPDV) stamme F93-125, inaktivert

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20090290A NO333242B1 (no) 2008-02-08 2009-01-20 Sammensetning, medisinsk anvendelse og fremgangsmate som omfatter salmonid alfavirus

Country Status (4)

Country Link
CA (2) CA2653300C (no)
CL (1) CL2009000287A1 (no)
GB (2) GB2493662B (no)
NO (2) NO333242B1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012130723A1 (en) 2011-03-25 2012-10-04 Intervet International B.V. Salmonid alphavirus vaccine
WO2014041189A1 (en) * 2012-09-17 2014-03-20 Novartis Ag Salmonid alphavirus and uses thereof
NO344938B1 (en) * 2018-12-13 2020-07-20 Patogen As Pancreas Disease Virus Markers
BE1028701B1 (nl) * 2020-10-13 2022-05-16 Poulpharm Bvba Werkwijze voor autovaccin productie en verkregen autovaccin
CN112877399B (zh) * 2021-01-20 2023-05-16 中国水产科学研究院黑龙江水产研究所 一种鲑鳟鱼致病菌药敏检测方法、药敏检测试剂盒及制备方法
WO2023034804A1 (en) * 2021-08-31 2023-03-09 Zoetis Services Llc Attenuated alphavirus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69531891D1 (de) * 1994-10-18 2003-11-13 Akzo Nobel Nv Virus, welches die Pankreas-Krankheit bei Fischen verursacht
ATE369429T1 (de) * 1998-05-08 2007-08-15 Intervet Int Bv Strukturproteine des virus, welches die pankreas- krankheit bei fischen verursacht, und ihre verwendungen
WO2003101482A2 (en) * 2002-05-31 2003-12-11 Genesis Group Inc. Liposome vaccine formulations for fin-fish
DK179025B1 (da) * 2005-09-16 2017-08-28 Intervet Int Bv Fiskevaccine
GB2452892B (en) * 2006-06-29 2011-10-12 Pharmaq As Process for culturing bacteria of the piscirickettsia genus

Also Published As

Publication number Publication date
GB0901913D0 (en) 2009-03-11
CA3090088C (en) 2023-01-31
CA2653300A1 (en) 2009-08-08
CA3090088A1 (en) 2009-08-08
GB2457158B (en) 2013-04-03
GB2493662B (en) 2013-04-17
GB2493662A (en) 2013-02-13
NO20090290L (no) 2009-08-10
GB2457158A (en) 2009-08-12
NO333242B1 (no) 2013-04-15
CL2009000287A1 (es) 2010-08-27
CA2653300C (en) 2020-11-17
GB201219654D0 (en) 2012-12-12

Similar Documents

Publication Publication Date Title
NO2015019I1 (no) Aeromonas salmonicida subspesie salmonicida,inaktivert/ Vibrio salmonicida,inaktivert/ Vibrio anguillarum serotype O1, inaktivert/Vibrio anguillarum serovar O2a, inaktivert/ Moritella viscosa, inaktivert/ Infeksiøs pankreasnekrosevirus (IPVN) serotype Sp/Laksespankreas sykdomsvirus (SPDV) stamme F93-125, inaktivert
BRPI0908763A2 (pt) Dispositivo, método para a obtenção de uma referência de freqüência e sistema.
BRPI0922309A2 (pt) método, meio legível por computador, e, aparelho.
BRPI0923304A2 (pt) método e aparelho para descobrir nós de transmissão.
BRPI0909124A2 (pt) métodos, aparelhos e produtos de programa de computador para prover separação criptográfica multi-salto para transferências
BRPI1012125A2 (pt) sistema, método e aparelho para inserção de sensor.
BRPI0818772A2 (pt) Dispositivo, método, e, meio legível por computador.
BRPI1011732A2 (pt) método de determinar coeficientes de um pré-distorcedor, meio legível por computador, e, cadeia de transmissão.
DK2183937T3 (da) Fremgangsmåder, apparater og computerprogramprodukt til inter-system overdragelse
BRPI0919487A2 (pt) sistema de geração de energia (pgs), e método de operar um sistema de geração de energia (pgs)
BRPI0924629A2 (pt) composição, e, método para remover placa das superfícies da cavidade oral.
DK2293804T3 (da) Herpes simplex virus (hsv) med modificeret tropisme, anvendelser deraf og fremgangsmåde til fremstilling deraf
BRPI0810114A2 (pt) Método para transmitir uma mensagem, e, nó de comunicação
BRPI1014580A2 (pt) amortecedor de ponta de pá, aparelho de transporte, e, arranjo de transporte.
BRPI0815605A2 (pt) sistema e método para autenticação, transferência de dados, e proteção contra roubo de identidade (phishing)
BRPI0918463A2 (pt) métodos para fabricar e para usar um instrumento endodôntico, e, instrumento endodôntico.
BRPI1015164A2 (pt) método e sistema para gerar automaticamente conteúdo específico de localização para uma entidade particular, e, método e sistema para fornecer conteúdo específico de localização para uma entidade particular tendo uma pluralidade de localizações físicas
BRPI0917254A2 (pt) método para remover um tampão, sistema, e aparelho
BRPI1008645A2 (pt) método, meio legível por computador, e, computador servidor
DK3156069T3 (da) Sammensætninger, fremgangsmåder, og kits til fremkaldelse af et immunrespons
BRPI0810865A2 (pt) antígenos de tripanossoma, composições vacinais, e métodos relacionados
BRPI1015948A2 (pt) propagação de informação promocional em uma rede social.
BR112013016683A2 (pt) oligodesoxinucleotídeo não metilado imunoestimulatório, vetor, vacina para prevenir ou combater uma doença infecciosa, célula, e, método para a detecção de oligodesoxinucleotídeos imunoestimulatórios.
DK2143792T3 (da) Enkelt-strenget, cyklisk RNA, og en fremgangsmåde til fremstilling deraf
BRPI0924053A2 (pt) método, aparelho e sistema para sincronização de tempo de xdsl

Legal Events

Date Code Title Description
MK1K Patent expired